Waist Circumference, Inflammation Key Predictors of Heart Failure Risk

The shape of our bodies, and how we measure them, may hold crucial clues to heart failure risk, according to research presented at the American Heart Association’s EPI | Lifestyle Scientific Sessions. A novel analysis suggests that waist circumference and the ratio of waist size to height are stronger indicators of potential heart failure and systemic inflammation than body mass index (BMI) alone. This finding underscores the importance of considering where fat is carried, not just how much, when assessing cardiovascular health.

Beyond BMI: Central Adiposity and Inflammation

For decades, BMI has been a standard tool for gauging weight-related health risks. But, it’s a blunt instrument, failing to distinguish between muscle mass and fat, or where fat is distributed. This new research, focusing on data from nearly 2,000 participants in the Jackson Heart Study, points to a more nuanced picture. Researchers found that systemic inflammation – measured by levels of high-sensitivity C-reactive protein (hs-CRP) – played a significant role in linking waist circumference and waist-to-height ratio to the development of heart failure. In fact, inflammation mediated over a quarter of the risk associated with these measures of central adiposity.

“This research helps us understand why some people develop heart failure despite having a body weight that seems healthy,” explained Szu-Han Chen, a medical student at National Yang Ming Chiao Tung University in Taiwan, in a press release. “By monitoring waist size and inflammation, clinicians may be able to identify people with higher risk earlier and focus on prevention strategies that could reduce the chance of heart failure before symptoms initiate.”

The Jackson Heart Study, a long-term investigation of cardiovascular health in African Americans, provided the data for this analysis. Participants without pre-existing heart failure were followed for a median of 6.9 years. Researchers assessed weight, BMI, waist circumference, and waist-to-height ratio, alongside hs-CRP levels. The results indicated that hs-CRP mediated the risk for adiposity-related HF more strongly when using waist circumference (HR = 1.31; 95% CI, 1.06-1.62; P = .014) and waist-to-height ratio (HR = 1.27; 95% CI, 1.02-1.58; P = .33) than with weight (P = .049) or BMI (P = .076). Further research has also highlighted the dangers of excess visceral abdominal fat.

Understanding Systemic Inflammation

Systemic inflammation is a complex process where the body’s immune system releases inflammatory molecules in response to various triggers, including excess visceral fat. Chronic inflammation is increasingly recognized as a key player in the development of numerous diseases, including cardiovascular disease. Visceral fat, the fat stored deep within the abdomen surrounding organs, is particularly problematic because it releases inflammatory substances more readily than fat stored elsewhere in the body. Light physical activity may also play a role in mitigating some of these risks.

Implications for Prevention and Clinical Practice

The study’s findings suggest that focusing solely on BMI may be insufficient for identifying individuals at risk of heart failure. Measuring waist circumference and assessing inflammation levels could provide a more comprehensive risk assessment. What we have is particularly important given that heart failure is a leading cause of hospitalization and death worldwide. The American Heart Association provides resources on understanding and preventing heart failure.

Sadiya S. Khan, MD, MSc, FAHA, Magerstadt Professor of Cardiovascular Epidemiology at Northwestern University Feinberg School of Medicine, who was not involved in the study, emphasized the importance of integrating central adiposity measures into routine preventive care. “Understanding upstream drivers of heart failure risk including central adiposity is key to recognizing and modifying risk,” she said in a press release. She also noted that this research builds upon previous function demonstrating the link between dysfunctional adiposity and heart failure, which informed the inclusion of BMI in PREVENT-HF risk equations.

The Role of Visceral Fat

Although the study doesn’t definitively prove that reducing waist circumference will prevent heart failure, it strengthens the argument for targeting visceral fat as a key component of cardiovascular disease prevention. Lifestyle interventions, such as diet and exercise, can assist reduce visceral fat and lower inflammation. However, more research is needed to determine the optimal strategies for targeting visceral fat and preventing heart failure.

Future Research Directions

Researchers acknowledge that further investigation is needed to determine whether central adiposity measures have greater predictive utility for heart failure risk than BMI alone. Future studies could explore the potential benefits of interventions specifically designed to reduce visceral fat and inflammation. Research is needed to identify the underlying mechanisms linking visceral fat, inflammation, and heart failure.

The Wyanoke Group, parent company of Healio, is dedicated to delivering high-quality information to healthcare professionals. Learn more about their mission and companies, including Healio, Healio LIVE, and SLACK Incorporated.

What remains to be seen: Whether incorporating waist circumference and hs-CRP levels into clinical guidelines will lead to improved heart failure prevention strategies. Ongoing research and clinical trials will be crucial in determining the optimal approach to risk assessment and management.